On day 7 after MALP2s/OVA treatment, OVA-specific CD8+ T cells had expanded in the spleen and infiltrated tumor tissue even without PD-L1 blockade (Figures S2A,B in Supplementary Material). The gene discussed is CD8A; the disease is neoplasm.